Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2025-12-25 @ 2:02 AM
NCT ID: NCT01698060
Eligibility Criteria: Inclusion Criteria: * Able and willing to complete informed consent * Healthy, as established by medical history, physical exam, and laboratory assessments * Has normal bowel movements * Willing to abstain from caffeine and xanthine containing substances for 24 hours before procedure until after discharge Exclusion Criteria: * Ability to donate up to 550 ml of blood over several months * Exposure to any investigational drug or vaccine 8 weeks prior to study * Has traveled to Asia within 8 weeks of enrollment * Abnormal ECG findings * History of irritable bowl or any other inflammatory gastrointestinal disorder * Any individual with increased risk for bowl obstruction * Radiation exposure above target values 50 mSv within the past 30 days or a cumulative dose above 150 mSv in the past 12 months * History of substance abuse * Subject unwilling to use an approved method of contraception during study and for 2 months after study * Positive for HCV, HIV, or HBV * Presence of an implantable device that is sensitive to radio frequencies (e.g. pacemakers) * History of an autoimmune disorder, or an immunosuppressive disorder * Stool sample with occult blood at baseline * Any other medical, psychiatric, social condition, or occupation, in the judgement of the investigator, is a contraindication to the compliance of the protocol or informed consent
Healthy Volunteers: True
Sex: MALE
Minimum Age: 18 Years
Maximum Age: 49 Years
Study: NCT01698060
Study Brief:
Protocol Section: NCT01698060